Back to Search
Start Over
Viral kinetics during the first month of treatment in patients with genotype 1 chronic hepatitis C.
- Source :
-
Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2009 Oct; Vol. 101 (10), pp. 671-9. - Publication Year :
- 2009
-
Abstract
- Objective: to identify predictive factors of response to pegylated interferon alpha-2b and ribavirin in patients with genotype 1 chronic hepatitis C. Viral kinetics were studied in weeks 2 and 4.<br />Methods: a prospective and consecutive study of patients with genotype 1 chronic hepatitis C referred to our Hepatology Clinic between January 2004 and October 2006 for antiviral treatment. Baseline data were recorded and viremia levels were determined hours before the weekly dose of pegylated interferon by qualitative and quantitative PCR.<br />Results: 57 patients were included in the study, although 3 of these were excluded during follow up; 65% were male (n = 35), with a mean age of 42 (26-65) years. Baseline viremia levels were > 800,000 IU/mL in 67% (n = 36). Liver biopsy was performed in 86% (n = 46), 22% (n = 12) had advanced fibrosis. Forty were naïve, 4 relapsing and 10 non-responders. Ribavirin dose was modified in one patient alone due to adverse effects. End treatment response and sustained virological response (SVR) were 59 and 41%, respectively. A univariate analysis revealed a statistically significant association of SVR with baseline viremia (p = 0.006), baseline GGT (p = 0.025), and a reduction in viremia > or =2 logs at 2, 4 and 12 weeks (p = 0.001). The extent of viremia reduction at week 2 was associated with 100% SVR, and at 4 weeks the positive predictive values was 84% and the negative predictive values was 96.5%. A subanalysis of the naïve group yielded analogous results.<br />Conclusions: in our study, a reduction in viremia > or = 2 logs 2 weeks after treatment could ensure SVR. At 4 weeks, most non-responders could be identified.
- Subjects :
- Adult
Aged
Female
Genotype
Hepacivirus classification
Hepacivirus genetics
Humans
Interferon alpha-2
Male
Middle Aged
Prospective Studies
Recombinant Proteins
Time Factors
Viremia virology
Antiviral Agents therapeutic use
Hepatitis C, Chronic drug therapy
Hepatitis C, Chronic virology
Interferon-alpha therapeutic use
Polyethylene Glycols therapeutic use
Ribavirin therapeutic use
Viral Load
Subjects
Details
- Language :
- English; Spanish; Castilian
- ISSN :
- 1130-0108
- Volume :
- 101
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Revista espanola de enfermedades digestivas
- Publication Type :
- Academic Journal
- Accession number :
- 19899935
- Full Text :
- https://doi.org/10.4321/s1130-01082009001000002